Networks of myelin covariance in relapsing-remitting multiple sclerosis

被引：0

作者：

Melie-Garcia, L. ^{[1
,2
,3
,4
]}

Barakovic, M. ^{[1
,2
,3
,4
]}

Weigel, M. ^{[1
,2
,3
,4
,5
]}

Chen, X. ^{[6
]}

Sanabria-Diaz, G. ^{[6
]}

Galbusera, R. ^{[1
,2
,3
,4
]}

Lu, P. -J. ^{[1
,2
,3
,4
]}

Cagol, A. ^{[1
,2
,3
,4
]}

Schaedelin, S. ^{[1
,7
]}

Benkert, P. ^{[1
,7
]}

Lutti, A. ^{[8
,9
]}

Ruberte, E. ^{[10
]}

Radue, E. -W. ^{[1
,2
]}

Kappos, L. ^{[1
,2
,3
,4
]}

Kuhle, J. ^{[1
,3
,4
]}

Granziera, C. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Hosp Basel, Basel, Switzerland

[2] Univ Basel, Translat Imaging Neurol ThINK Basel, Dept Med & Biomed Engn, Basel, Switzerland

[3] Univ Basel, Neurol Clin & Policlin, MS Ctr, Basel, Switzerland

[4] Univ Basel, Res Ctr Clin Neuroimmunol & Neurosci Basel RC2NB, Basel, Switzerland

[5] Univ Hosp Basel, Div Radiol Phys, Dept Radiol, Basel, Switzerland

[6] Univ Basel, Translat Imaging Neurol ThINK, Dept Biomed Engn, Basel, Switzerland

[7] Univ Basel, Clin Trial Unit, Dept Clin Res, Basel, Switzerland

[8] Lausanne Univ Hosp, Lausanne, Switzerland

[9] Univ Lausanne, Lab Res Neuroimaging, Dept Clin Neurosci, Lausanne, Switzerland

[10] MIAC, Basel, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P192

引用

页码：257 / 258

页数：2

共 50 条

[31] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
Herwerth, Marina
Hemmer, Bernhard
EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
[32] A CASE OF RELAPSING-REMITTING TUMEFACTIVE MULTIPLE SCLEROSIS
Turnbull, H.
Karsan, N.
Hogg, F.
Pereira, A.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83
[33] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
Fox, Edward J.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
[34] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
Hersh, Carrie M.
Cohen, Jeffrey A.
IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
[35] Natalizumab in spinal relapsing-remitting multiple sclerosis
Zecca, C.
Kamm, C.
Riccitelli, G. C.
Heldner, M.
Caporro, M.
Gobbi, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
[36] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
Menge, Til
Dubey, Divyanshu
Warnke, Clemens
Hartung, Hans-Peter
Stuve, Olaf
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
[37] Development of laquinimod for relapsing-remitting multiple sclerosis
Jeffery, Douglas R.
FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
[38] Oral fingolimod for relapsing-remitting multiple sclerosis
Doggrell, Sheila A.
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
[39] Intravenous immunoglobulin in relapsing-remitting multiple sclerosis
Achiron, A
Barak, Y
SarovaPinhas, I
Achiron, R
Gabbay, U
Rotstein, Z
Noy, S
INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 289 - 293
[40] Cognitive Impairment In Relapsing-Remitting Multiple Sclerosis
Topcular, Baris
Ozcan, M. Emin
Kurt, Elif
Kuscu, Demet Yandim
Icen, Nilufer Kale
Sutlas, Pakize Nevin
Kirbas, Dursun
Bingol, Ayhan
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (03): : 178 - 182

← 1 2 3 4 5 →